ah 6809 has been researched along with 8-bromo cyclic adenosine monophosphate in 2 studies
Studies (ah 6809) | Trials (ah 6809) | Recent Studies (post-2010) (ah 6809) | Studies (8-bromo cyclic adenosine monophosphate) | Trials (8-bromo cyclic adenosine monophosphate) | Recent Studies (post-2010) (8-bromo cyclic adenosine monophosphate) |
---|---|---|---|---|---|
163 | 1 | 49 | 3,707 | 5 | 198 |
Protein | Taxonomy | ah 6809 (IC50) | 8-bromo cyclic adenosine monophosphate (IC50) |
---|---|---|---|
cAMP-specific 3',5'-cyclic phosphodiesterase 4A | Homo sapiens (human) | 7.7 | |
cAMP-specific 3',5'-cyclic phosphodiesterase 4B | Homo sapiens (human) | 7.7 | |
cAMP-specific 3',5'-cyclic phosphodiesterase 4C | Homo sapiens (human) | 7.7 | |
cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Homo sapiens (human) | 7.7 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andelfinger, G; Bouayad, A; Chemtob, S; Clyman, RI; Fouron, JC; Gobeil, F; Kajino, H; Skoll, A; Varma, DR; Vazquez, A; Waleh, N | 1 |
Belvisi, MG; Catley, MC; Clarke, DL; Giembycz, MA; Newton, R; Yacoub, MH | 1 |
2 other study(ies) available for ah 6809 and 8-bromo cyclic adenosine monophosphate
Article | Year |
---|---|
Characterization of PGE2 receptors in fetal and newborn lamb ductus arteriosus.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Adenosine Triphosphate; Alprostadil; Animals; Animals, Newborn; Anti-Arrhythmia Agents; Anti-Ulcer Agents; Binding, Competitive; Biphenyl Compounds; Colforsin; Dinoprost; Ductus Arteriosus; Female; Fetus; Polymerase Chain Reaction; Potassium Channels; Pregnancy; Prostaglandin Antagonists; Prostaglandins E, Synthetic; Radioligand Assay; Receptors, Prostaglandin E; Sheep; Tritium; Vasoconstriction; Xanthenes; Xanthones | 2001 |
Identification in human airways smooth muscle cells of the prostanoid receptor and signalling pathway through which PGE2 inhibits the release of GM-CSF.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 8-Bromo Cyclic Adenosine Monophosphate; Adenoviridae; Adolescent; Adult; Aged; Alprostadil; Cell Survival; Cyclic AMP-Dependent Protein Kinases; Dinoprostone; Enzyme Inhibitors; Female; Gene Expression; Genetic Vectors; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Indomethacin; Interleukin-1; Isoquinolines; Male; Middle Aged; Misoprostol; Myocytes, Smooth Muscle; Prostaglandins E, Synthetic; Protein Isoforms; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP2 Subtype; Receptors, Prostaglandin E, EP4 Subtype; Signal Transduction; Sulfonamides; Trachea; Xanthones | 2004 |